UiPath Inc.

NYSE:PATH

12.73 (USD) • At close June 27, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q1
Revenue 356.624423.646354.653316.253335.112405.253325.921287.31289.588308.549262.744242.222245.066289.698220.816195.521186.217207.875147.289139.376113.103
Cost of Revenue 63.85764.53463.76363.3255.91654.0749.9248.98743.66747.69142.76844.57645.01641.16443.135.59449.0120.13617.38514.69813.638
Gross Profit 0359.112290.89252.933279.196351.183276.001238.323245.921260.858219.976197.646200.05248.534177.716159.927137.207187.739129.904124.67899.465
Gross Profit Ratio 00.8480.820.80.8330.8670.8470.8290.8490.8450.8370.8160.8160.8580.8050.8180.7370.9030.8820.8950.879
Reseach & Development Expenses 098.4896.97698.43385.60385.63984.51486.60675.34281.8767.34167.84968.6964.41261.55957.64693.0429.19427.45626.54126.729
General & Administrative Expenses -159.66148.99750.0963.51963.5159.45256.02459.57756.58450.37563.15768.44357.5360.24459.49855.83474.41544.57465.95124.83426.676
Selling & Marketing Expenses 159.661170.398187.188194.33180.139191.717191.282169.725160.406173.76156.469181.547189.782174.757172.906144.268205.75199.3899.51290.33190.931
SG&A 0220.061237.278257.849243.058250.454247.306229.302216.99224.135219.626249.99247.312235.001232.404200.102280.166143.954165.463115.165117.607
Other Expenses 292.7677.3170010.6796.28413.7257.4724.29400.888-0.6-2.811-4.745-4.3-1.225-3.2184.643-6.30324.01-7.837
Operating Expenses 309.179325.503334.254356.282328.661336.093331.82315.908292.332306.005286.967317.839316.002299.413293.963257.748373.206173.148192.919141.706144.336
Operating Income -16.41233.609-43.364-103.349-49.46515.09-55.819-77.585-46.411-45.147-66.991-120.193-115.952-50.879-116.247-97.821-235.99914.591-63.015-17.028-44.871
Operating Income Ratio -0.0460.079-0.122-0.327-0.1480.037-0.171-0.27-0.16-0.146-0.255-0.496-0.473-0.176-0.526-0.5-1.2670.07-0.428-0.122-0.397
Total Other Income Expenses Net 021.01517.86521.0824.50921.50128.20821.05418.14218.18810.4493.905-1.82-3.8-3.401-0.459-2.2775.044-6.15924.087-7.307
Income Before Tax 054.624-25.499-82.269-24.95636.596-27.611-56.531-28.269-26.959-56.542-116.288-117.772-54.679-119.648-98.28-238.27619.635-69.1747.059-52.178
Income Before Tax Ratio 00.129-0.072-0.26-0.0740.09-0.085-0.197-0.098-0.087-0.215-0.48-0.481-0.189-0.542-0.503-1.280.094-0.470.051-0.461
Income Tax Expense 02.83-14.8443.8283.782.683.9263.833.6320.731.1824.094.7898.4313.1391.7461.387-6.6211.6222.0720.662
Net Income -22.55551.794-10.655-86.097-28.73633.916-31.537-60.361-31.901-27.689-57.724-120.378-122.561-63.11-122.787-100.026-239.66326.256-70.7964.987-52.84
Net Income Ratio -0.0630.122-0.03-0.272-0.0860.084-0.097-0.21-0.11-0.09-0.22-0.497-0.5-0.218-0.556-0.512-1.2870.126-0.4810.036-0.467
EPS -0.0410.09-0.02-0.15-0.050.06-0.056-0.11-0.057-0.05-0.1-0.22-0.23-0.12-0.23-0.19-1.110.12-0.140.01-0.11
EPS Diluted -0.0410.09-0.02-0.15-0.050.058-0.056-0.11-0.057-0.05-0.1-0.22-0.23-0.12-0.23-0.19-1.110.12-0.140.01-0.11
EBITDA -13.15936.824-38.83-98.768-44.56318.932-50.399-70.324-39.906-36.297-58.105-110.424-109.154-47.809-110.083-92.181-231.09317.143-60.296-14.211-42.024
EBITDA Ratio -0.0370.087-0.109-0.312-0.1330.047-0.155-0.245-0.138-0.118-0.221-0.456-0.445-0.165-0.499-0.471-1.2410.082-0.409-0.102-0.372